Meiland Ruby, Stolk Ronald P, Geerlings Suzanne E, Peeters Petra H M, Grobbee Diederick E, Coenjaerts Frank E J, Brouwer Ellen C, Hoepelman Andy I M
Department of Internal Medicine and Infectious Diseases, University Medical Center, Utrecht, the Netherlands.
Arch Intern Med. 2007 Feb 12;167(3):253-7. doi: 10.1001/archinte.167.3.253.
We sought to investigate whether Escherichia coli bacteriuria is associated with a decline in renal function or with the development of end-stage renal failure after long-term follow-up.
We performed a full cohort analysis for women who participated in 2 population-based studies. The baseline cohort consisted of women who collected morning midstream urine samples that were stored. In the cohort study, the presence of E coli bacteriuria was subsequently determined by real-time polymerase chain reaction. After a mean +/- SD follow-up of 11.5 +/- 1.7 years, blood samples were drawn from 490 women. In the nested case-control study, cases comprised all women who underwent kidney therapy (hemodialysis or renal transplantation) between participation in the baseline cohort study and a mean +/- SD of 13.8 +/- 7.4 years later.
The mean +/- SD age at baseline was 45.0 +/- 3.2 years, and 48 women (10%) had E coli bacteriuria. After 11.5 years, the mean +/- SD creatinine clearance (Cockroft-Gault formula) was similar between the 2 groups (87 +/- 21 mL/min [1.5 +/- 0.4 mL/s] and 85 +/- 18 mL/min [1.4 +/- 0.3 mL/s] for women who had and those who did not have bacteriuria, respectively). In the nested case-control study, the prevalence of E coli bacteriuria was 14% among cases and control subjects. The odds ratio corrected for age for the development of end-stage renal failure in the presence of E coli bacteriuria at baseline was 1.1 (95% confidence interval, 0.4-2.8; P = .86).
Escherichia coli bacteriuria is not associated with a decline in renal function or with the development of end-stage renal failure in a population of generally healthy women during 12 to 14 years of follow-up.
我们试图研究长期随访后,大肠杆菌菌尿症是否与肾功能下降或终末期肾衰竭的发生有关。
我们对参与两项基于人群研究的女性进行了全队列分析。基线队列由收集并储存晨尿中段尿样本的女性组成。在队列研究中,随后通过实时聚合酶链反应确定大肠杆菌菌尿症的存在。在平均±标准差为11.5±1.7年的随访后,从490名女性中采集了血样。在巢式病例对照研究中,病例包括在参与基线队列研究后至平均±标准差为13.8±7.4年期间接受肾脏治疗(血液透析或肾移植)的所有女性。
基线时的平均±标准差年龄为45.0±3.2岁,48名女性(10%)有大肠杆菌菌尿症。11.5年后,两组的平均±标准差肌酐清除率(Cockcroft-Gault公式)相似(有菌尿症的女性为87±21 mL/min [折合1.5±0.4 mL/s],无菌尿症的女性为85±18 mL/min [折合1.4±0.3 mL/s])。在巢式病例对照研究中,病例组和对照组中大肠杆菌菌尿症的患病率均为14%。基线时存在大肠杆菌菌尿症的情况下,校正年龄后终末期肾衰竭发生的比值比为1.1(95%置信区间,0.4 - 2.8;P = .86)。
在一般健康的女性人群中,经过12至14年的随访,大肠杆菌菌尿症与肾功能下降或终末期肾衰竭的发生无关。